LG Life Sciences has been producing Hyaluronic Acid materials for more than 15 years.
The treatment systems with these Hyaluronic Acid materials have been exported around the world.
YVOIRE is composed of the cross-linked hyaluronic acid with a high molecular weight of an average 3 million Dalton to maintain the shin supporting effects for a long time.
YVOIRE uses a little amount of cross-linking agent during the cross-linking procedure of HA through high HA concentration and the maximisation of HA dispersion with the cross-linking agent. Therefore, YVOIRE is able to produce leading HA filler with high elasticity.
The unique syringe design is the result of reflecting the opinion of leading clinicians which means it will be able to help with an effective and comfortable filler injection.
LG Chems' non-animal origin HA has been marketed in various medical fields since 1995 with proven safety and efficacy. Its high molecular weight HA has been approved by the European Directorate for the Quality of Medicines and its drug master file to the US FDA
HICE Cross-linking Technology
HICE Cross-linking Technology, which enables to reach the maximum cross-linking ratio despite of "minimal use of cross-linkers" by dispersing the cross-linkers into highly concentrated HA during cross-linking reaction.
High Cross-linking Ratio means Efficient Cross-linking
Microscopic view of YVOIRE Contour
In YVOIRE contour, fine particles of cross-linked HA fills the void between around the large main particles, resulting in smoother surface on the correction areas as well as continuous, uniform and flowing injection sensation regardless of its larger average particle size.